|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 | (2006.01) |
| C12Q 1/6886 | (2013.01) | ||
| C12Q 1/6886 | (2018.01) | ||
| C12Q2600/106 | (2013.01) | ||
| C12Q2600/158 | (2013.01) |
| (11) | Number of the document | 3795698 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20204903.7 |
| Date of filing the European patent application | 2015-05-07 | |
| (97) | Date of publication of the European application | 2021-03-24 |
| (45) | Date of publication and mention of the grant of the patent | 2023-03-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201461991710 P | 2014-05-12 | US |
| (72) |
SOKOL RICCI, Deborah , US
LI, Weimin , US
GORMLEY, Michael , US
KARKERA, Jayaprakash , US
SCHAFFER, Michael , US
|
| (73) |
Janssen Pharmaceutica NV ,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | BIOLOGICAL MARKERS FOR IDENTIFYING PATIENTS FOR TREATMENT WITH ABIRATERONE ACETATE |
| BIOLOGICAL MARKERS FOR IDENTIFYING PATIENTS FOR TREATMENT WITH ABIRATERONE ACETATE |